title: Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue.
authors.affiliation: University of Utah, Department of Neurology, Salt Lake City, UT, United States. Electronic address: DonRaphael.Wynn@hsc.utah.edu.
authors.forename: DonRaphael
authors.initials: D
authors.lastname: Wynn
authors.affiliation: University of Utah, Department of Internal Medicine, Salt Lake City, UT, United States. Electronic address: Joseph.Merriman@hsc.utah.edu.
authors.forename: Joseph
authors.initials: J
authors.lastname: Merriman
authors.affiliation: University of Utah, Division of Oncology, Huntsman Cancer Institute, Salt Lake City, UT, United States. Electronic address: Ami.Patel@hci.utah.edu.
authors.forename: Ami B
authors.initials: AB
authors.lastname: Patel
authors.affiliation: University of Utah, Department of Radiation Oncology, Huntsman Cancer Institute, Salt Lake City, UT, United States. Electronic address: Ying.Hitchcock@hci.utah.edu.
authors.forename: Ying J
authors.initials: YJ
authors.lastname: Hitchcock
authors.affiliation: University of Utah, Division of Oncology, Huntsman Cancer Institute, Salt Lake City, UT, United States. Electronic address: Ignacio.Garrido-Laguna@hci.utah.edu.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Garrido-Laguna
authors.affiliation: University of Utah, Department of Neurology, Salt Lake City, UT, United States. Electronic address: David.Renner@hsc.utah.edu.
authors.forename: David
authors.initials: D
authors.lastname: Renner
authors.affiliation: University of Utah, Department of Neurology, Salt Lake City, UT, United States. Electronic address: Stacey.Clardy@hsc.utah.edu.
authors.forename: Stacey L
authors.initials: SL
authors.lastname: Clardy
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015835:Ocular Motility Disorders / Q000209:etiology*; D010257:Paraneoplastic Syndromes / Q000209:etiology*; D014062:Tongue Neoplasms / Q000150:complications*
keywords: GAD65 antibodies; Opsoclonus; Paraneoplastic syndrome; Squamous cell carcinoma